Passage Bio, Inc.PASGNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank86
3Y CAGR+71.2%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

3Y CAGR
+71.2%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
5x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202534.30%
202438.73%
202333.79%
20226.83%
2021-57.57%
2020-101.82%
2019-114.88%
20180.00%